Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Trading Floor Community IconFrom the Trading Floor:
Regeneron Pharmaceuticals, Inc. Logo

Combined Holdings of Regeneron (REGN) - Updated Daily

Lock IconJoin Premium Plan
The Bucket Report Icon
Download ARK WatchlistsDownload ARK holdings as watchlists that can be imported into TradingView and Interactive Brokers
Date
Direction
Shares
Fund Weight
Fund
March 14, 2022SELL4.785k0.099%ARKG
February 4, 2022SELL3.261k0.0525%ARKG
February 1, 2022SELL1.400k0.0208%ARKG
January 28, 2022SELL3.206k0.0539%ARKG
December 14, 2021SELL4.092k0.051%ARKG

Key Statistics

DateMay 04, 2022Revenue
Expected0
Actual$2.97b
EPS
Expected$9.89
Actual$11.49
🕵🏼Found In🏷Last Price
ARKG$661.14
⚖️Weighting🧢Market Cap
0.25%$72.62b
🏋️‍♀️Weight Rank Across All Funds🧮Price to Sales
694.4
💳ARK Estimated Cost Average🌏Country
$503.96 - ARKG$518.24 - ARKK
🇺🇸United States
🎫ARK Ownership Percent
0.05%
Description
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in its laboratories. Its medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases and rare diseases.
Website
www.regeneron.com

Research Notes and Commentary for REGN